Alessandro Zuppardo

Alessandro Zuppardo

Auto-generated profile, based on publicly available information

Alessandro Zuppardo

Department of Biomedical Sciences, University of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2025 in Nature Communications
Verified
Journal Article
Open access
SCSamantha Corrà
Samantha Corrà
AZAlessandro Zuppardo
Alessandro Zuppardo
SVSebastian Valenzuela
Sebastian Valenzuela
LJLouise Jenninger
Louise Jenninger
RCRaffaele Cerutti
Raffaele Cerutti
Carlo ViscomiCarlo Viscomi
Carlo Viscomi
DNA polymerase γ (POLγ), responsible for mitochondrial DNA replication, consists of a catalytic POLγA subunit and two accessory POLγB subunits. Mutations in POLG, which encodes POLγA, lead to various mitochondrial diseases. We investigated the most common POLG mutations (A467T, W748S, G848S, Y955C) by characterizing human and mouse POLγ variants. Our data reveal that these mutations significantly impair POLγ activities, with mouse variants exhibiting milder defects. Cryogenic electron microscopy highlighted structural differences between human and mouse POLγ, particularly in the POLγB subunit, which may explain the higher activity of mouse POLγ and the reduced severity of mutations in mice. We further generated a panel of mouse models mirroring common human POLG mutations, providing crucial insights into the pathogenesis of POLG-related disorders and establishing robust models for therapeutic development. Our findings emphasize the importance of POLγB in modulating the severity of POLG mutations.

26 December 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RCRaquel Brañas Casas
Raquel Brañas Casas
GRGiovanni Risato
Giovanni Risato
AZAlessandro Zuppardo
Alessandro Zuppardo
Carlo ViscomiCarlo Viscomi
Carlo Viscomi
Francesco ArgentonFrancesco Argenton
Francesco Argenton
Natascia TisoNatascia Tiso
Natascia Tiso
Mitochondrial genetic diseases are complex disorders that impair cellular energy production, leading to diverse clinical manifestations across multiple organ systems. These diseases arise from mutations in either mitochondrial DNA or nuclear DNA. Among nuclear DNA-related cases, mutations in POLG and POLG2 , which encode subunits of mitochondrial DNA polymerase γ, are particularly significant, causing conditions such as Alpers–Huttenlocher syndrome and progressive external ophthalmoplegia. Model organisms have been instrumental in elucidating POLG-related disease mechanisms and advancing therapeutic strategies. Saccharomyces cerevisiae (budding yeast) provided insights into fundamental mitochondrial functions, while Caenorhabditis elegans (roundworm) helped explore POLG’s roles in multicellular organisms. Drosophila melanogaster (fruit fly) has been pivotal in studying neurological aspects, and Mus musculus (mouse) models contributed to understanding systemic effects in mammals. Recently, Danio rerio (zebrafish) has emerged as a promising vertebrate model for drug screening, due to its optical transparency and genetic tractability. Each model system offers unique advantages, collectively bridging the gap between basic research and clinical applications. This review will examine in vivo models used in POLG disorder research, highlighting their contributions to understanding disease mechanisms and therapeutic advancements.

31 August 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RCRaquel Brañas Casas
Raquel Brañas Casas
GRGiovanni Risato
Giovanni Risato
AZAlessandro Zuppardo
Alessandro Zuppardo
Carlo ViscomiCarlo Viscomi
Carlo Viscomi
Francesco ArgentonFrancesco Argenton
Francesco Argenton
Natascia TisoNatascia Tiso
Natascia Tiso